N-((R)-.alpha.-methyl-3-methoxybenzyl)-3-(2-chlorobenzene)propanamide
AssigneeNPS Pharmaceuticals, Inc.
InventorsBradford C. VanWagenen, Steven R. Duff, William A. Nelson
Life of this patent
Estimating the term…
Loading patent…
AssigneeNPS Pharmaceuticals, Inc.
InventorsBradford C. VanWagenen, Steven R. Duff, William A. Nelson
Estimating the term…
A method of making ( R)- N-[1-(3-methoxyphenyl)ethyl]-3-(2-chlorobenzene)propanamine which involves reducing the appropriate amidyl or iminyl precursor with an appropriate reducing agent. The appropriate amidyl or iminyl precursor is made from a synthesis involving the use of ( R)-3-methoxy-.alpha.-methylbenzylamine. A method of condensing a nitrile with a primary or secondary amine to form an imine involves the reaction of a nitrile with diisobutylaluminum hydride; and then reacting the resultant compound with a primary or secondary amine to form the imine. The process is especially useful for producing enantiomerically pure chiral imines, and, ultimately, amines. Typical such imines have the formula: ##STR1## wherein R, R.sub.1, R.sub.2 and R.sub.3 are independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, aryl and aralkyl.
The compound N-(R)-.alpha.-methyl-3-methoxybenzyl) -3-(2-chlorobenzene)propanamide.
Dependencies are inferred from the claim text.